newsfilter
← Latest News
GlobeNewswire·

Finch Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates

Completed upsized IPO, raising $130.8 million in gross proceeds Topline safety and efficacy data from more than 130 recurrent CDI patients treated with CP101 in PRISM-EXT expected in H2 2021 Strengthened leadership team with the appointment of Susan E